Lucid Diagnostics Inc reports results for the quarter ended in December - Earnings Summary

Lucid Diagnostics

14/03/2023 13:32

* Lucid Diagnostics Inc  LUCD.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 38 cents per share.
    * Revenue fell 62.7% to $112.00 thousand from a year ago;
analysts
expected $343.80 thousand. 
    * Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lucid Diagnostics Inc shares had risen by 18.4% this
quarter.
    * The company reported a quarterly loss of $20.46 million.
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 14 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.38          -0.23          Beat
 Sep. 30 2022      -0.40          -0.39          Beat
 Jun. 30 2022      -0.36          -0.41          Missed
 Mar. 31 2022      -0.33          -0.35          Missed